Skip to main content

Table 2 Recurrent tumor distribution (n = 51)

From: 18F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications

 

Numbers (%)

Pelvis

 Pelvic tumor

7 (13.7%)

 Vaginal cuff tumor

6 (11.8%)

 Pelvic peritoneum

1 (2.0%)

 Rectal tumor

1 (2.0%)

Peritoneal carcinomatosis

8 (15.7%)

Lymph node metastases

 Multiple lymph nodes

7 (13.7%)

 Peri-aortic lymph node

1 (2.0%)

 Retro-pancreatic lymph node

1 (2.0%)

Supra-diaphragmatic lymph node

1 (2.0%)

Lung metastasis

2 (3.9%)

Spleen metastasis

1 (2.0%)

Liver metastasis

2 (3.9%)

Hepatorenal recess tumor

3 (5.9%)

Left-side diaphragmatic tumor

1 (2.0%)

Mesocolic tumor and paracolic tumor

3 (5.9%)

Abdominal wall tumor

4 (7.8%)

Intestinal mesentery

2 (3.9%)